EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice

Barkha J Yadav-Samudrala iD, Havilah P Ravula, Karenna M Barmada, Hailey Dodson, Justin L Poklis, Bogna M Ignatowska-Jankowska, Aron H Lichtman iD, Kathryn J Reissner, Sylvia Fitting

Cannabis & Cannabinoid Research · 2024

DOI: 10.1089/can.2023.0247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, 2024. Verfasst von Barkha J Yadav-Samudrala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Endocannabinoids, Monoacylglycerol Lipases, Locomotion, Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence suggests that monoacylglycerol lipase (MAGL) inhibitors can potentially treat HIV symptoms by increasing the concentration of 2-arachidonoylglycerol (2-AG). We examined a selective MAGL inhibitor ABX1431 in the context of neuroHIV.

Methods

To assess the effects of ABX1431, we conducted in vitro and in vivo studies. In vitro calcium imaging on frontal cortex neuronal cultures was performed to evaluate the role of ABX1431 (10, 30, 100 nM) on transactivator of transcription (Tat)-induced neuronal hyperexcitability. Following in vitro experiments, in vivo experiments were performed using Tat transgenic male mice. Mice were treated with 4 mg/kg ABX1431 and assessed for antinociception using tail-flick and hot plate assays followed by locomotor activity. After the behavioral experiments, their brains were harvested to quantify endocannabinoids (eCB) and related lipids through mass spectrometry, and cannabinoid type-1 and -2 receptors (CB 1 R and CB 2 R) were quantified through western blot.

Results

In vitro studies revealed that adding Tat directly to the neuronal cultures significantly increased intracellular calcium concentration, which ABX1431 completely reversed at all concentrations. Preincubating the cultures with CB 1 R and CB 2 R antagonists showed that ABX1431 exhibited its effects partially through CB 1 R. In vivo studies demonstrated that acute ABX1431 increased overall total distance traveled and speed of mice regardless of their genotype. Mass spectrometry and western blot analyses revealed differential effects on the eCB system based on Tat expression. The 2-AG levels were significantly upregulated following ABX1431 treatment in the striatum and spinal cord. Arachidonic acid (AA) was also upregulated in the striatum of vehicle-treated Tat(+) mice. No changes were noted in CB 1 R expression levels; however, CB 2 R levels were increased in ABX1431-treated Tat(−) mice only.

Conclusion

Findings indicate that ABX1431 has potential neuroprotective effects in vitro partially mediated through CB 1 R. Acute treatment of ABX1431 in vivo shows antinociceptive effects, and seems to alter locomotor activity, with upregulating 2-AG levels in the striatum and spinal cord.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsMonoacylglycerol LipasesLocomotionNeuronstat Gene Products, Human Immunodeficiency VirusMice, TransgenicAnimalsMaleMiceNociceptionArachidonic AcidsGlyceridesReceptor, Cannabinoid, CB1HIV-1Enzyme InhibitorsReceptor, Cannabinoid, CB2PiperidinesBenzodioxoles

Stichwörter der Autor:innen

2-arachidonoylglycerolTat transgenic mousearachidonic acidmonoacylglycerol lipaseneuroHIVnociception

Substanzen

EndocannabinoidsMonoacylglycerol Lipasestat Gene Products, Human Immunodeficiency VirusArachidonic Acidsglyceryl 2-arachidonate1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo(d)(1,3)dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylateGlyceridesReceptor, Cannabinoid, CB1Enzyme InhibitorsReceptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Neuronal Rhythms in Movement Unit, Okinawa Institute of Science and Technology, Okinawa, Japan.

ORCID-Profile: Barkha J Yadav-Samudrala, Aron H Lichtman

Förderung

  • NIDA NIH HHS

Zitieren

APA

Yadav-Samudrala, B. J., Ravula, H. P., Barmada, K. M., Dodson, H., Poklis, J. L., Ignatowska-Jankowska, B. M., Lichtman, A. H., Reissner, K. J., & Fitting, S. (2024). Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice. Cannabis & Cannabinoid Research. https://doi.org/10.1089/can.2023.0247

Vancouver

Yadav-Samudrala BJ, Ravula HP, Barmada KM, Dodson H, Poklis JL, Ignatowska-Jankowska BM, et al. Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice. Cannabis & Cannabinoid Research. 2024. doi:10.1089/can.2023.0247

BibTeX
@article{YadavSamudrala2024,
  author = {Yadav-Samudrala, Barkha J and Ravula, Havilah P and Barmada, Karenna M and Dodson, Hailey and Poklis, Justin L and Ignatowska-Jankowska, Bogna M and Lichtman, Aron H and Reissner, Kathryn J and Fitting, Sylvia},
  title = {Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice},
  journal = {Cannabis & Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2023.0247}
}
Kostenlos starten →